Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system

Immunotherapy for malignant tumors is a hot spot in current research and the treatment of cancer. The activation of programmed cell death receptor‐1 (PD‐1) and cytotoxic T lymphocyte‐associated antigen 4 (CTLA)‐4 relevant signaling pathway can inhibit the activation of T lymphocytes. Tumor cells can...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Thorac Cancer
Asıl Yazarlar: Li, Yue, Kang, Xiaohui, Wang, Hanping, Guo, Xiaoxiao, Zhou, Jiaxin, Duan, Lian, Si, Xiaoyan, Zhang, Li, Liu, Xiaowei, Qian, Jiaming
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons Australia, Ltd 2020
Konular:
Invited Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113043/
https://ncbi.nlm.nih.gov/pubmed/32107847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13338
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller